OriginCell

About:

OriginCell is a biomedical equipment enterprise that develops tumor immuno-therapy solutions.

Website: http://www.origincell-auto.com

Top Investors: Qiming Venture Partners, Quan Capital, CTS Capital, C&D Emerging Investment, Shanghai Gui Guo Assets Management Partnership

Description:

OriginCell is a biomedical equipment enterprise that develops tumor immuno-therapy solutions. It develops tumor therapies and cellular drugs through the use of the 10-phage display library, humanized antibody technology platform, and antibody discovery platform that enable their medical facilities to apply in cancer treatments. OriginCell was founded in 2014 and is headquartered in Shanghai, China.

Total Funding Amount:

$197M

Headquarters Location:

Pudong, Shandong, China

Founded Date:

2014-01-01

Contact Email:

equipments(AT)origincell.com

Founders:

He Xiaowen, Jianguo Qu

Number of Employees:

1-10

Last Funding Date:

2022-08-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai